{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:36:35Z","timestamp":1792654595115,"version":"4.5.0"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001530","name":"Canterbury Medical Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001530","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005468","name":"Batten Disease Support and Research Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005468","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Experimental Eye Research"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/j.exer.2021.108600","type":"journal-article","created":{"date-parts":[[2021,4,28]],"date-time":"2021-04-28T01:53:00Z","timestamp":1619574780000},"page":"108600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"special_numbering":"C","title":["Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease"],"prefix":"10.1016","volume":"207","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4847-2205","authenticated-orcid":false,"given":"Samantha J.","family":"Murray","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina N.","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0621-212X","authenticated-orcid":false,"given":"Tracy R.","family":"Melzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J.","family":"Gray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J.","family":"Heap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9703-5351","authenticated-orcid":false,"given":"David N.","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia L.","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.exer.2021.108600_bib1","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/gt.2016.31","article-title":"Reduced retinal transduction and enhanced transgene-directed immunogenicity with intravitreal delivery of rAAV following posterior vitrectomy in dogs","volume":"23","author":"Boyd","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2021.108600_bib2","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/gt.2015.96","article-title":"Photoreceptor-targeted gene delivery using intravitreally administered AAV vectors in dogs","volume":"23","author":"Boyd","year":"2016","journal-title":"Gene Ther."},{"key":"10.1016\/j.exer.2021.108600_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v080.i01","article-title":"Brms: an R package for bayesian multilevel models using stan","volume":"80","author":"B\u00fcrkner","year":"2017","journal-title":"J. Stat. Software"},{"key":"10.1016\/j.exer.2021.108600_bib4","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1016\/j.bbadis.2015.05.014","article-title":"Towards a new understanding of NCL pathogenesis","volume":"1852","author":"Cooper","year":"2015","journal-title":"BBA-Mol. Basis. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib5","doi-asserted-by":"crossref","first-page":"189ra76","DOI":"10.1126\/scitranslmed.3005708","article-title":"In vivo\u2013directed evolution of a new adeno-associated virus for therapeutic outer retinal gene delivery from the vitreous","volume":"5","author":"Dalkara","year":"2013","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2021.108600_bib6","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1038\/mt.2009.181","article-title":"Inner limiting membrane barriers to AAV-mediated retinal transduction from the vitreous","volume":"17","author":"Dalkara","year":"2009","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.nbd.2007.09.006","article-title":"A new large animal model of CLN5 neuronal ceroid lipofuscinosis in Borderdale sheep is caused by a nucleotide substitution at a consensus splice site (c.571+1G>A) leading to excision of exon 3","volume":"29","author":"Frugier","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib8","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1001\/archophthalmol.2010.210","article-title":"Improvement of visual performance with intravitreal administration of 9-cis-retinal in Rpe65-mutant dogs","volume":"128","author":"Gearhart","year":"2010","journal-title":"Arch. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108600_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/0002-9394(74)90601-1","article-title":"The fine structure of the retina in neuronal ceroid-lipofuscinosis","volume":"77","author":"Goebel","year":"1974","journal-title":"Am. J. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108600_bib10","first-page":"241","article-title":"Ultrastructural studies on the retina in human and canine neuronal ceroid-lipofuscinoses and other lysosomal disorders","volume":"18","author":"Goebel","year":"1982","journal-title":"Birth Defects-Orig"},{"key":"10.1016\/j.exer.2021.108600_bib11","first-page":"294","article-title":"Ceroid-lipofuscinosis (Batten's disease). Sequential electrophysiologic and pathologic changes in the retina of the ovine model","volume":"25","author":"Graydon","year":"1984","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.exer.2021.108600_bib12","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1038\/mt.2015.187","article-title":"Production of recombinant adeno-associated virus vectors using suspension HEK293 cells and continuous harvest of vector from the culture media for GMP FIX and FLT1 clinical vector","volume":"24","author":"Grieger","year":"2016","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib13","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ymthe.2005.04.018","article-title":"AAV2-mediated ocular gene therapy for infantile neuronal ceroid lipofuscinosis","volume":"12","author":"Griffey","year":"2005","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib14","series-title":"Ceroid-Lipofuscinosis (Batten's Disease)","first-page":"61","article-title":"Neurophysiological studies (EEG\/ERG\/VEP\/SEP) in 88 children with so-called neuronal ceroid lipofuscinosis","author":"Harden","year":"1982"},{"key":"10.1016\/j.exer.2021.108600_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.nbd.2003.12.019","article-title":"The mouse ortholog of the neuronal ceroid lipofuscinosis CLN5 gene encodes a soluble lysosomal glycoprotein expressed in the developing brain","volume":"16","author":"Holmberg","year":"2004","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1016\/j.visres.2004.03.023","article-title":"The allometry and scaling of the size of vertebrate eyes","volume":"44","author":"Howland","year":"2004","journal-title":"Vis. Res."},{"key":"10.1016\/j.exer.2021.108600_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1080\/00480169.2002.36311","article-title":"Neuronal ceroid-lipofuscinosis in Borderdale sheep","volume":"50","author":"Jolly","year":"2002","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.exer.2021.108600_bib18","series-title":"Ceroid-Lipofuscinosis (Batten's Disease)","first-page":"218","article-title":"Ceroid-Lipofuscinosis: the ovine model","author":"Jolly","year":"1982"},{"key":"10.1016\/j.exer.2021.108600_bib19","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1111\/j.1365-2990.1989.tb01236.x","article-title":"Ceroid\u2013lipofuscinosis (batten's disease): pathogenesis and sequential neuropathological changes in the ovine model","volume":"15","author":"Jolly","year":"1989","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.exer.2021.108600_bib20","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1080\/00480169.1976.34298","article-title":"Blindness in South Hampshire sheep: a neuronal ceroid lipofuscinosis","volume":"24","author":"Jolly","year":"1976","journal-title":"N. Z. Vet. J."},{"key":"10.1016\/j.exer.2021.108600_bib21","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1126\/scitranslmed.aac6191","article-title":"AAV gene transfer delays disease onset in a TPP1-deficient canine model of the late infantile form of Batten disease","volume":"7","author":"Katz","year":"2015","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.exer.2021.108600_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/99ee1789-a658-4fb0-8593-40a40e9f344a","article-title":"Targeting photoreceptors via intravitreal delivery using novel, capsid-mutated AAV vectors","volume":"8","author":"Kay","year":"2013","journal-title":"PloS One"},{"key":"10.1016\/j.exer.2021.108600_bib23","first-page":"40","article-title":"Vector Considerations for Ocular Gene Therapy. Adeno-associated virus vectors offer a safe and effective tool for gene delivery","author":"Kiss","year":"2020","journal-title":"Retin. Physician"},{"key":"10.1016\/j.exer.2021.108600_bib24","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/hum.2020.038","article-title":"Gene therapy targeting the inner retina rescues the retinal phenotype in a mouse model of CLN3 batten disease","volume":"31","author":"Kleine Holthaus","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2021.108600_bib25","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/j.ymthe.2018.02.027","article-title":"Prevention of photoreceptor cell loss in a Cln6 mouse model of batten disease requires CLN6 gene transfer to bipolar cells","volume":"26","author":"kleine Holthaus","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib26","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s40263-019-00620-8","article-title":"Current and emerging treatment strategies for neuronal ceroid lipofuscinoses","volume":"33","author":"Kohlsch\u00fctter","year":"2019","journal-title":"CNS Drugs"},{"key":"10.1016\/j.exer.2021.108600_bib27","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/path.4641","article-title":"Animal modelling for inherited central vision loss","volume":"238","author":"Kostic","year":"2016","journal-title":"J. Pathol."},{"key":"10.1016\/j.exer.2021.108600_bib28","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/humu.21624","article-title":"Update of the mutation spectrum and clinical correlations of over 360 mutations in eight genes that underlie the neuronal ceroid lipofuscinoses","volume":"33","author":"Kousi","year":"2012","journal-title":"Hum. Mutat."},{"key":"10.1016\/j.exer.2021.108600_bib29","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2990.1985.tb00025.x","article-title":"Ceroid-lipofuscinosis (Batten's disease): pathogenesis of blindness in the ovine model","volume":"11","author":"Mayhew","year":"1985","journal-title":"Neuropathol. Appl. Neurobiol."},{"key":"10.1016\/j.exer.2021.108600_bib30","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1016\/j.ymthe.2018.07.015","article-title":"Longitudinal in vivo monitoring of the CNS demonstrates the efficacy of gene therapy in a sheep model of CLN5 batten disease","volume":"26","author":"Mitchell","year":"2018","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib31","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S1474-4422(18)30368-5","article-title":"Clinical challenges and future therapeutic approaches for neuronal ceroid lipofuscinosis","volume":"18","author":"Mole","year":"2019","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.exer.2021.108600_bib32","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/j.bbadis.2015.05.011","article-title":"Genetics of the neuronal ceroid lipofuscinoses (Batten disease)","volume":"1852","author":"Mole","year":"2015","journal-title":"BBA-Mol. Basis. Dis., Current Research on the Neuronal Ceroid Lipofuscinoses (Batten Disease)"},{"key":"10.1016\/j.exer.2021.108600_bib33","series-title":"The Neuronal Ceroid Lipofuscinoses (Batten Disease)","author":"Mole","year":"2011"},{"key":"10.1016\/j.exer.2021.108600_bib34","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s10048-005-0218-3","article-title":"Correlations between genotype, ultrastructural morphology and clinical phenotype in the neuronal ceroid lipofuscinoses","volume":"6","author":"Mole","year":"2005","journal-title":"Neurogenetics"},{"key":"10.1016\/j.exer.2021.108600_bib35","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.nbd.2005.01.025","article-title":"Glial activation spreads from specific cerebral foci and precedes neurodegeneration in presymptomatic ovine neuronal ceroid lipofuscinosis (CLN6)","volume":"20","author":"Oswald","year":"2005","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib36","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1146\/annurev-med-122313-085916","article-title":"Lysosomal storage diseases: from pathophysiology to therapy","volume":"66","author":"Parenti","year":"2015","journal-title":"Annu. Rev. Med."},{"key":"10.1016\/j.exer.2021.108600_bib37","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1016\/j.bbadis.2015.05.007","article-title":"Human NCL neuropathology","volume":"1852","author":"Radke","year":"2015","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.exer.2021.108600_bib38","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ajmg.1320310606","article-title":"Batten disease: past, present, and future","volume":"31","author":"Rider","year":"1988","journal-title":"Am. J. Med. Genet."},{"key":"10.1016\/j.exer.2021.108600_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1089\/hum.2020.023","article-title":"Evaluation of photoreceptor transduction efficacy of capsid-modified adeno-associated viral vectors following intravitreal and subretinal delivery in sheep","volume":"31","author":"Ross","year":"2020","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.exer.2021.108600_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.dib.2021.107188","article-title":"Electroretinography data from ovine models of CLN5 and CLN6 neuronal ceroid lipofuscinoses","author":"Russell","year":"2021","journal-title":"Data In Brief"},{"key":"10.1016\/j.exer.2021.108600_bib41","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1016\/j.ymthe.2006.01.006","article-title":"Gene therapy for lysosomal storage diseases","volume":"13","author":"Sands","year":"2006","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib42","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.nbd.2011.12.009","article-title":"Cln5-deficiency in mice leads to microglial activation, defective myelination and changes in lipid metabolism","volume":"46","author":"Schmiedt","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib43","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.ejpb.2015.01.009","article-title":"Retinal gene delivery by adeno-associated virus (AAV) vectors: strategies and applications","volume":"95","author":"Sch\u00f6n","year":"2015","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.exer.2021.108600_bib44","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1463-5224.2008.00619.x","article-title":"Experimental determination and allometric prediction of vitreous volume, and retina and lens weights in G\u00f6ttingen minipigs","volume":"11","author":"Shafiee","year":"2008","journal-title":"Vet. Ophthalmol."},{"key":"10.1016\/j.exer.2021.108600_bib45","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1002\/cne.22333","article-title":"Topography of ganglion cells and photoreceptors in the sheep retina","volume":"518","author":"Shinozaki","year":"2010","journal-title":"J. Comp. Neurol."},{"key":"10.1016\/j.exer.2021.108600_bib46","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1089\/hum.2012.253","article-title":"Partial correction of the CNS lysosomal storage defect in a mouse model of juvenile neuronal ceroid lipofuscinosis by neonatal CNS administration of an adeno-associated virus serotype rh.10 vector expressing the human CLN3 gene","volume":"25","author":"Sondhi","year":"2013","journal-title":"Hum. Gene Ther."},{"issue":"552","key":"10.1016\/j.exer.2021.108600_bib47","first-page":"554","article-title":"[Aging and age-related changes of the vitreous body]","volume":"112","author":"Spitzer","year":"2015","journal-title":"Ophthalmologe"},{"key":"10.1016\/j.exer.2021.108600_bib48","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.ymthe.2016.10.008","article-title":"Improved intravitreal AAV-mediated inner retinal gene transduction after surgical internal limiting membrane peeling in cynomolgus monkeys","volume":"25","author":"Takahashi","year":"2017","journal-title":"Mol. Ther."},{"key":"10.1016\/j.exer.2021.108600_bib49","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/j.bbadis.2006.09.004","article-title":"A missense mutation (c.184C>T) in ovine CLN6 causes neuronal ceroid lipofuscinosis in Merino sheep whereas affected South Hampshire sheep have reduced levels of CLN6 mRNA","volume":"1762","author":"Tammen","year":"2006","journal-title":"BBA-Mol. Basis. Dis."},{"key":"10.1016\/j.exer.2021.108600_bib50","doi-asserted-by":"crossref","first-page":"1260419","DOI":"10.1126\/science.1260419","article-title":"Proteomics. Tissue-based map of the human proteome","volume":"347","author":"Uhl\u00e9n","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.exer.2021.108600_bib51","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/nbt1210-1248","article-title":"Towards a knowledge-based human protein atlas","volume":"28","author":"Uhlen","year":"2010","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.exer.2021.108600_bib52","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1038\/eye.1998.148","article-title":"The dystrophic retina in multisystem disorders: the electroretinogram in neuronal ceroid lipofuscinoses","volume":"12","author":"Weleber","year":"1998","journal-title":"Eye"},{"key":"10.1016\/j.exer.2021.108600_bib53","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.ymgme.2004.06.019","article-title":"Electroretinographic and clinicopathologic correlations of retinal dysfunction in infantile neuronal ceroid lipofuscinosis (infantile Batten disease)","volume":"83","author":"Weleber","year":"2004","journal-title":"Mol. Genet. Metabol."},{"key":"10.1016\/j.exer.2021.108600_bib54","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.exer.2016.03.023","article-title":"Intracerebroventricular gene therapy that delays neurological disease progression is associated with selective preservation of retinal ganglion cells in a canine model of CLN2 disease","volume":"146","author":"Whiting","year":"2016","journal-title":"Exp. Eye Res."},{"key":"10.1016\/j.exer.2021.108600_bib55","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00261","article-title":"Immunology of AAV-mediated gene transfer in the eye","volume":"4","author":"Willett","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.exer.2021.108600_bib56","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.pediatrneurol.2017.01.034","article-title":"Management strategies for CLN2 disease","volume":"69","author":"Williams","year":"2017","journal-title":"Pediatr. Neurol."},{"key":"10.1016\/j.exer.2021.108600_bib57","doi-asserted-by":"crossref","first-page":"2775","DOI":"10.1167\/iovs.10-6250","article-title":"Intravitreal injection of AAV2 transduces macaque inner retina","volume":"52","author":"Yin","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."}],"container-title":["Experimental Eye Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014483521001664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T05:32:29Z","timestamp":1762147949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014483521001664"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,6]]},"references-count":57,"alternative-id":["S0014483521001664"],"URL":"https:\/\/doi.org\/10.1016\/j.exer.2021.108600","relation":{},"ISSN":["0014-4835"],"issn-type":[{"value":"0014-4835","type":"print"}],"subject":[],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intravitreal gene therapy protects against retinal dysfunction and degeneration in sheep with CLN5 Batten disease","name":"articletitle","label":"Article Title"},{"value":"Experimental Eye Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.exer.2021.108600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108600"}}